Biopreservation Market Size, Share & Trends

Biopreservation Market by Product (Media [Cryopreservation, Hypothermic]), Equipment (Freezers, Refrigerators, Incubators, Centrifuge, Accessories), Biospecimen (Tissues, Organs, Stem Cells), Application (Research, Therapeutic) - Global Forecast to 2029

Report Code: BT 1305 May, 2024, by marketsandmarkets.com

Updated on : September 24, 2024

Overview of the Biopreservation Market

Key entities in the global biopreservation market include major players like Thermo Fisher and Merck. Biopreservation market forecasted to transform from $4.4 billion in 2024 to $7.1 billion by 2029, driven by a CAGR of 9.8%. This expansion is largely driven by increasing healthcare expenditures, particularly in organ transplants and cell therapies, as highlighted by a 4.1% increase in U.S. healthcare spending in 2022. However, high costs associated with advanced storage techniques and logistical challenges in maintaining sample integrity could hinder market growth. Notably, biobanks are emerging as a dominant end-user segment due to government investments and collaborative research efforts. The equipment segment is expected to experience the highest growth, while North America remains the leading region, supported by substantial research funding and the presence of major industry players. With ongoing advancements in biopreservation technologies and increasing demand for biomedical research, the market presents numerous opportunities for stakeholders in healthcare and research sectors.

Biopreservation Market Trends

Biopreservation Market

To know about the assumptions considered for the study, Request for Free Sample Report

Biopreservation Market

Market Dynamics

DRIVER: Growing healthcare expenditure

Innovative medical procedures such as organ transplants, stem cell therapy, and regenerative medicine will be on the rise with the increasing healthcare expenditure. These procedures require frequent preservation of biological samples such as tissues, cells, and organs, which will result in the increased demand for biopreservation products that can effectively retain the vitality of these materials while preserving. According to the American Medical Association (AMA), in 2022, the healthcare expenditure in the US increased by 4.1%, reaching USD 4.4 trillion or USD 13,493 per person.  Similarly, Canada’s total health spending was expected to reach USD 344 billion (12% of GDP) in 2023, or USD 8,740 per Canadian.

RESTRAINT: High cost of advanced techniques

Biopreservation is of outmost importance in the storage of bio samples. This involves the specific use of media and equipment, such as freezers, refrigerators, or cryogenic and other expensive storage equipment. Because of the components involved, the media solutions for organs, as well as for cells and tissues, are expensive to produce. Equipment like liquid nitrogen storage systems and tanks, are a one-time investment for storage and transport in which huge capital is involved in the initial stages of establishing a biopreservation setup. For instance, Thermo Fisher Value Lab Upright freezers cost USD 3,510, TSX Universal ULT Freezer costs range from USD 11,600 to USD 89,400, VWR CryoPro Standard Auto-Fill Systems costs range from USD 30,766 to USD 54,341, VWR CryoPro AFX Auto-Fill Systems costs range from USD 20,847 to USD 23,762, and the MVE Fusion Series Freezers costs range from USD 51,295 to USD 62,528.

OPPORTUNITY: Growing demand for organ transplants and cell & gene therapy

Organs like heart or lung can be kept viable for transplantation for only six hours, pancreas or liver for 12 hours, and a kidney for less than 30 hours. Hence, to maintain a proper condition, it is very important to preserve these organs. The aim of the preservation is to ensure the optimal functionality of the organ after transplantation so that the damage during this time is minimal. Degenerative reactions take place when the organ is removed from the donor, this is because of the alteration of homeostasis of the organ; therefore, it is very crucial to properly preserve the organs. Moreover, the rise in the number of cell and gene therapy products in development will support the demand for biopreservation solutions to store and manage biological materials used in these therapies, which includes cells, tissues, and viral vectors. This is due to increasing investments in cell and gene therapy R&D which has led to the significant growth of the therapy pipeline, with more candidate therapies advancing into clinical trials and commercialization.

CHALLENGE: Storage and transportation logistics

Ensuring the viability and integrity of preserved biological materials is technically challenging. Issues such as ice crystal formation during freezing, contamination risks, and sample degradation over time pose significant hurdles. Maintaining consistent quality control standards is also resource intensive. Furthermore, biological samples often need to be transported at consistent low temperatures to prevent degradation. Any break in the cold chain can compromise sample viability.

Ecosystem/ Market Map

Prominent companies in this market include well-established, financially stable manufacturers of Biopreservation. These companies have been operating in the market for several years and possess diversified state-of-the-art technologies, product portfolios, and strong global sales and marketing networks. Prominent companies in this market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), PHC Holdings Corporation (Japan), and Azenta, Inc. (US).

Biopreservation Market Ecosystem

In 2023, biopreservation equipment segment to observe the highest growth rate of the biopreservation industry, by product.

Based on product, the biopreservation market is segmented into media, equipment, and accessories. The biopreservation media segment accounted for the largest market share in 2023. This is attributed to the frequent and repeated purchase of media when compared to equipment, and the media reflects their versatility and importance in preserving biological samples for diverse purposes.

In 2023, research application segment to dominate the biopreservation industry, by application.

Based on the application, the biopreservation market is segmented into therapeutic applications, research applications, and other applications. The research applications segment accounted for the largest market share in 2023. The growing research investments in biomedical research, personalized medicine, cell-based research, drug discovery, and other related segments will drive the market during the forecast period.

In 2023, biobanks segment to dominate the biopreservation industry, by end user.

Based on the end user, the biopreservation market is segmented into biobanks, gene banks, hospitals, and other end users such as research institutes and universities, pharmaceutical companies, and contract research organizations. The biobanks segment accounted for the largest share of the market in 2023. Advances in biobanks, more number of investments by the government in the biobanking sector, and collaborative research activities are supporting the growth of this end-user segment.

In 2023, North America to dominate in biopreservation industry.

The global biopreservation market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC. North America is expected to dominate during the forecast period, primarily due to the growing availability of government funding for research activities and healthcare spending, the presence of major players in the US, and increased collaborations and partnerships between biobanks and research institutes.

Biopreservation Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The Biopreservation market is dominated by players such as Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), PHC Holdings Corporation (Japan), Azenta, Inc. (US), Sartorius AG (Germany), Avantor, Inc. (US), ThermoGenesis Holdings, Inc. (US), Bio-Techne Corporation (US), BioLife Solutions Inc. (US), and Cryoport Inc. (US).

Report Scope

Report Metric

Details

Market Revenue in 2024

$4.4 billion

Projected Revenue by 2029

$7.1 billion

Revenue Rate

Poised to Grow at a CAGR of 9.8%

Market Driver

Growing healthcare expenditure

Market Opportunity

Growing demand for organ transplants and cell & gene therapy

Report Segmentation

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
  • GCC

By Product

  • Biopreservation Media
  • Biopreservation Equipment
  • Biopreservation Accessories

By Biospecimen

  • Human Tissue Samples
  • Organs
  • Stem Cell
  • Other Biospecimen

BY Application

  • Therapeutic Application
  • Research Application
  • Other Applications

By End User

  • Biobanks
  • Gene Banks
  • Hospitals
  • Other End Users

Recent Developments

  • In 2024, Merck invested more than USD 321.7 million (EUR 300 million) into a new Bioprocessing Production Center in Daejeon, South Korea. The new site is the largest investment by Merck’s Life Science business sector in the Asia Pacific to date and demonstrates the company’s commitment to expanding its capacities in the fast-growing region. Merck expects the investment to create approximately 300 additional jobs by the end of 2028.
  • In 2024, Thermo Fisher Scientific introduced its newest line of high-performance, ultra-low temperature (ULT) freezers. With enhancements to performance, user experience, and energy efficiency, the Thermo Scientific TSX Universal Series ULT Freezers seamlessly adapt to scientists’ workflows across a variety of lab settings, marking a new era in performance, reliability, and sustainability.
  • In 2023, Avantor entered into an agreement with Tobin Scientific, a leading provider of biopharma cold chain, ambient storage, and transport & logistics services, to support end-to-end moves for US biopharma customers looking to relocate the labs, research facilities, and samples. This partnership will deal with the growing customer need for complex logistics solutions with temperature-specific requirements.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
 
4 PREMIUM INSIGHTS (Page No. - 49)
    4.1 BIOPRESERVATION MARKET OVERVIEW 
    4.2 ASIA PACIFIC: BIOPRESERVATION MARKET, BY BIOSPECIMEN AND COUNTRY (2023) 
    4.3 BIOPRESERVATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
    4.4 BIOPRESERVATION MARKET: REGIONAL MIX 
    4.5 BIOPRESERVATION MARKET: DEVELOPED VS. DEVELOPING MARKETS 
 
5 MARKET OVERVIEW (Page No. - 53)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           5.2.1 DRIVERS
                    5.2.1.1 Growing healthcare expenditure
                    5.2.1.2 Increasing R&D investments
                    5.2.1.3 Advances in biobanking and growing trend of conserving cord blood stem cells of newborns
                    5.2.1.4 Rising investments in regenerative medicine research
                    5.2.1.5 Increasing demand for personalized medicine
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of advanced techniques
                    5.2.2.2 Stability issues due to tissue injury during freezing and thawing
                    5.2.2.3 Issues related to biospecimen sample management
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Asia offers significant growth opportunities
                    5.2.3.2 Rising demand for organ transplants and cell & gene therapy
           5.2.4 CHALLENGES
                    5.2.4.1 Increasing demand for room temperature storage technologies
                    5.2.4.2 Storage and transportation logistics
    5.3 PRICING ANALYSIS 
    5.4 PATENT ANALYSIS 
    5.5 VALUE CHAIN ANALYSIS 
    5.6 SUPPLY CHAIN ANALYSIS 
    5.7 ECOSYSTEM ANALYSIS 
           5.7.1 BIOPRESERVATION MARKET: ROLE IN ECOSYSTEM
    5.8 PORTER’S FIVE FORCES ANALYSIS 
           5.8.1 THREAT OF NEW ENTRANTS
           5.8.2 THREAT OF SUBSTITUTES
           5.8.3 BARGAINING POWER OF SUPPLIERS
           5.8.4 BARGAINING POWER OF BUYERS
           5.8.5 INTENSITY OF COMPETITIVE RIVALRY
    5.9 REGULATORY ANALYSIS 
           5.9.1 US
           5.9.2 EUROPEAN UNION
    5.10 TRADE ANALYSIS 
    5.11 TECHNOLOGY ANALYSIS 
           5.11.1 KEY TECHNOLOGIES
                    5.11.1.1 Cryopreservation
                    5.11.1.2 Hypothermic preservation
           5.11.2 ADJACENT TECHNOLOGIES
                    5.11.2.1 Normothermic machine perfusion
    5.12 KEY CONFERENCES AND EVENTS IN 2024–2025 
    5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 
           5.13.1 REVENUE SHIFT IN BIOPRESERVATION
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
           5.14.2 BUYING CRITERIA
    5.15 INVESTMENT AND FUNDING SCENARIO 
 
6 BIOPRESERVATION MARKET, BY PRODUCT (Page No. - 81)
    6.1 INTRODUCTION 
    6.2 BIOPRESERVATION MEDIA 
           6.2.1 CRYOPRESERVATION MEDIA
                    6.2.1.1 Largest and fastest-growing segment of biopreservation media market
           6.2.2 HYPOTHERMIC PRESERVATION MEDIA
                    6.2.2.1 Increase in organ transplants to support segment growth
    6.3 BIOPRESERVATION EQUIPMENT 
           6.3.1 TEMPERATURE CONTROL SYSTEMS
                    6.3.1.1 Freezers
                               6.3.1.1.1 Growing demand for advanced energy-efficient ultra-low-temperature freezers to propel market
                    6.3.1.2 Cryogenic storage systems
                               6.3.1.2.1 Used for storage of samples below -130°C
                    6.3.1.3 Thawing equipment
                               6.3.1.3.1 Rapid thawing essential for ideal preservation of cells
                    6.3.1.4 Refrigerators
                               6.3.1.4.1 Used for storage of samples at constant temperature
           6.3.2 ALARM MONITORING SYSTEMS
                    6.3.2.1 Help scrutinize proper functioning of biopreservation equipment
           6.3.3 INCUBATORS
                    6.3.3.1 Help maintain favorable environment for cell growth
           6.3.4 CENTRIFUGES
                    6.3.4.1 Used for isolating and separating suspensions and immiscible liquids
           6.3.5 OTHER BIOPRESERVATION EQUIPMENT
    6.4 BIOPRESERVATION ACCESSORIES 
           6.4.1 INDISPENSABLE AND INTEGRAL COMPONENTS OF BIOPRESERVATION PROCEDURES
 
7 BIOPRESERVATION MARKET, BY BIOSPECIMEN (Page No. - 114)
    7.1 INTRODUCTION 
    7.2 HUMAN TISSUE SAMPLES 
           7.2.1 GROWTH IN R&D SPENDING FOR LIFE SCIENCE RESEARCH TO DRIVE MARKET
    7.3 ORGANS 
           7.3.1 INCREASING NUMBER OF ORGAN TRANSPLANTS TO DRIVE MARKET GROWTH
    7.4 STEM CELLS 
           7.4.1 ADVANCEMENTS IN STEM CELL THERAPY TO PROPEL MARKET
    7.5 OTHER BIOSPECIMENS 
 
8 BIOPRESERVATION MARKET, BY APPLICATION (Page No. - 125)
    8.1 INTRODUCTION 
    8.2 RESEARCH APPLICATIONS 
           8.2.1 GOVERNMENT INITIATIVES TO SUPPORT MARKET GROWTH
    8.3 THERAPEUTIC APPLICATIONS 
           8.3.1 INCREASING UTILIZATION OF STEM CELLS FOR TREATMENT OF DISEASES TO DRIVE MARKET
    8.4 OTHER APPLICATIONS 
 
9 BIOPRESERVATION MARKET, BY END USER (Page No. - 134)
    9.1 INTRODUCTION 
    9.2 BIOBANKS 
           9.2.1 INCREASING RESEARCH IN FIELD OF PERSONALIZED MEDICINE TO DRIVE MARKET
    9.3 GENE BANKS 
           9.3.1 GROWING GENE THERAPY APPROVALS TO SUPPORT MARKET GROWTH
    9.4 HOSPITALS 
           9.4.1 GROWING NUMBER OF ORGAN TRANSPLANT PROCEDURES TO PROPEL MARKET
    9.5 OTHER END USERS 
 
10 BIOPRESERVATION MARKET, BY REGION (Page No. - 146)
     10.1 INTRODUCTION 
     10.2 NORTH AMERICA 
             10.2.1 RECESSION IMPACT: NORTH AMERICA
             10.2.2 US
                        10.2.2.1 High incidence of chronic and genetic diseases to drive market
             10.2.3 CANADA
                        10.2.3.1 Government funding for research and innovation to support market growth
     10.3 EUROPE 
             10.3.1 EUROPE: RECESSION IMPACT
             10.3.2 GERMANY
                        10.3.2.1 Presence of advanced infrastructure to propel market
             10.3.3 UK
                        10.3.3.1 High R&D expenditure to drive market
             10.3.4 FRANCE
                        10.3.4.1 Advances in research activities to support market growth
             10.3.5 ITALY
                        10.3.5.1 Increase in life sciences research projects to drive market
             10.3.6 SPAIN
                        10.3.6.1 Government initiatives for development of healthcare system to support market growth
             10.3.7 REST OF EUROPE
     10.4 ASIA PACIFIC 
             10.4.1 ASIA PACIFIC: RECESSION IMPACT
             10.4.2 CHINA
                        10.4.2.1 High research and development expenditure to propel market
             10.4.3 JAPAN
                        10.4.3.1 Government initiatives to support market growth
             10.4.4 INDIA
                        10.4.4.1 Increasing investments in research activities to support market growth
             10.4.5 REST OF ASIA PACIFIC
     10.5 LATIN AMERICA 
             10.5.1 LATIN AMERICA: RECESSION IMPACT
             10.5.2 BRAZIL
                        10.5.2.1 High investments in pharmaceutical R&D to propel market
             10.5.3 MEXICO
                        10.5.3.1 Growth in pharmaceutical industry to support market growth
             10.5.4 REST OF LATIN AMERICA
     10.6 MIDDLE EAST & AFRICA 
             10.6.1 GROWING INVESTMENTS IN STEM CELL RESEARCH TO DRIVE MARKET
             10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
     10.7 GCC COUNTRIES 
             10.7.1 INCREASING HEALTHCARE SPENDING TO DRIVE MARKET
             10.7.2 GCC COUNTRIES: RECESSION IMPACT
 
11 COMPETITIVE LANDSCAPE (Page No. - 217)
     11.1 OVERVIEW 
     11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
     11.3 REVENUE ANALYSIS 
     11.4 MARKET SHARE ANALYSIS 
     11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
             11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                        11.5.5.1 Company footprint
                        11.5.5.2 Regional footprint
                        11.5.5.3 Product footprint
                        11.5.5.4 Biospecimen footprint
                        11.5.5.5 Application footprint
     11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 STARTING BLOCKS
             11.6.3 RESPONSIVE COMPANIES
             11.6.4 DYNAMIC COMPANIES
             11.6.5 COMPETITIVE BENCHMARKING
             11.6.6 COMPANY FOOTPRINT: STARTUPS/SMES, 2023
                        11.6.6.1 Company footprint
                        11.6.6.2 Product footprint
                        11.6.6.3 Regional footprint
     11.7 VALUATION & FINANCIAL METRICS 
     11.8 BRAND/PRODUCT COMPARISON 
     11.9 COMPETITIVE SCENARIO 
             11.9.1 PRODUCT LAUNCHES
             11.9.2 DEALS
             11.9.3 EXPANSIONS
 
12 COMPANY PROFILES (Page No. - 236)
     12.1 KEY PLAYERS 
             12.1.1 THERMO FISHER SCIENTIFIC INC.
                        12.1.1.1 Business overview
                        12.1.1.2 Products offered
                        12.1.1.3 Recent developments
                                     12.1.1.3.1 Product launches
                        12.1.1.4 MnM view
                                     12.1.1.4.1 Key strengths
                                     12.1.1.4.2 Strategic choices
                                     12.1.1.4.3 Weaknesses and competitive threats
             12.1.2 MERCK KGAA
                        12.1.2.1 Business overview
                        12.1.2.2 Products offered
                        12.1.2.3 Recent developments
                                     12.1.2.3.1 Expansions
                        12.1.2.4 MnM view
                                     12.1.2.4.1 Key strengths
                                     12.1.2.4.2 Strategic choices
                                     12.1.2.4.3 Weaknesses and competitive threats
             12.1.3 PHC HOLDINGS CORPORATION
                        12.1.3.1 Business overview
                        12.1.3.2 Products offered
                        12.1.3.3 Recent developments
                        12.1.3.4 MnM view
                                     12.1.3.4.1 Key strengths
                                     12.1.3.4.2 Strategic choices
                                     12.1.3.4.3 Weaknesses and competitive threats
             12.1.4 AZENTA, INC.
                        12.1.4.1 Business overview
                        12.1.4.2 Products offered
                        12.1.4.3 Recent developments
                                     12.1.4.3.1 Product launches
                                     12.1.4.3.2 Deals
             12.1.5 AVANTOR, INC.
                        12.1.5.1 Business overview
                        12.1.5.2 Products offered
                        12.1.5.3 Recent developments
                                     12.1.5.3.1 Deals
             12.1.6 SARTORIUS AG
                        12.1.6.1 Business overview
                        12.1.6.2 Products offered
             12.1.7 THERMOGENESIS HOLDINGS, INC.
                        12.1.7.1 Business overview
                        12.1.7.2 Products offered
                        12.1.7.3 Recent developments
                                     12.1.7.3.1 Expansions
             12.1.8 BIO-TECHNE CORPORATION
                        12.1.8.1 Business overview
                        12.1.8.2 Products offered
             12.1.9 BIOLIFE SOLUTIONS INC.
                        12.1.9.1 Business overview
                        12.1.9.2 Products offered
                        12.1.9.3 Recent developments
                                     12.1.9.3.1 Product launches
                                     12.1.9.3.2 Deals
             12.1.10 CRYOPORT INC.
                        12.1.10.1 Business overview
                        12.1.10.2 Products offered
                        12.1.10.3 Recent developments
                                     12.1.10.3.1 Deals
             12.1.11 SO-LOW ENVIRONMENTAL EQUIPMENT CO.
                        12.1.11.1 Business overview
                        12.1.11.2 Products offered
     12.2 OTHER PLAYERS 
             12.2.1 SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.
             12.2.2 HELMER SCIENTIFIC INC.
             12.2.3 ARCTIKO
             12.2.4 NIPPON GENETICS EUROPE
             12.2.5 STEMCELL TECHNOLOGIES, INC.
             12.2.6 AMSBIO
             12.2.7 OPS DIAGNOSTICS
             12.2.8 ASKION GMBH
             12.2.9 DOHMEYER
             12.2.10 X-THERMA, INC.
             12.2.11 IC BIOMEDICAL, LLC
             12.2.12 TAIYO NIPPON SANSO CORPORATION
             12.2.13 FROILABO
             12.2.14 CELLBIOS HEALTHCARE & LIFESCIENCES PVT. LTD.
 
13 APPENDIX (Page No. - 292)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 
 
 
LIST OF TABLES (361 TABLES)
 
TABLE 1 INCLUSIONS AND EXCLUSIONS OF STUDY
TABLE 2 KEY DATA FROM PRIMARY SOURCES
TABLE 3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
TABLE 4 AVERAGE SELLING PRICE TREND, BY REGION
TABLE 5 BIOPRESERVATION MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 6 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 EXPORT DATA FOR HS CODE 841869, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 12 IMPORT DATA FOR HS CODE 841869, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 13 BIOPRESERVATION MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS
TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOPRESERVATION PRODUCTS, BY END USER
TABLE 15 KEY BUYING CRITERIA, BY END USER
TABLE 16 BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 17 BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 18 BIOPRESERVATION MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 19 NORTH AMERICA: BIOPRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 20 EUROPE: BIOPRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 21 ASIA PACIFIC: BIOPRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 22 LATIN AMERICA: BIOPRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 23 CRYOPRESERVATION MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 24 NORTH AMERICA: CRYOPRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 25 EUROPE: CRYOPRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 26 ASIA PACIFIC: CRYOPRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 27 LATIN AMERICA: CRYOPRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 28 HYPOTHERMIC PRESERVATION MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 29 NORTH AMERICA: HYPOTHERMIC PRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 30 EUROPE: HYPOTHERMIC PRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 ASIA PACIFIC: HYPOTHERMIC PRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 32 LATIN AMERICA: HYPOTHERMIC PRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 33 BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 34 BIOPRESERVATION EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 35 NORTH AMERICA: BIOPRESERVATION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 36 EUROPE: BIOPRESERVATION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 37 ASIA PACIFIC: BIOPRESERVATION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38 LATIN AMERICA; BIOPRESERVATION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 39 TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 40 TEMPERATURE CONTROL SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 41 NORTH AMERICA: TEMPERATURE CONTROL SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 42 EUROPE: TEMPERATURE CONTROL SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 43 ASIA PACIFIC: TEMPERATURE CONTROL SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 44 LATIN AMERICA: TEMPERATURE CONTROL SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 45 FREEZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 46 NORTH AMERICA: FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 47 EUROPE: FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 ASIA PACIFIC: FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 49 LATIN AMERICA: FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 50 CRYOGENIC STORAGE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 51 NORTH AMERICA: CRYOGENIC STORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 52 EUROPE: CRYOGENIC STORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 53 ASIA PACIFIC: CRYOGENIC STORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 54 LATIN AMERICA: CRYOGENIC STORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 55 THAWING EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 56 NORTH AMERICA: THAWING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 57 EUROPE: THAWING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 58 ASIA PACIFIC: THAWING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 59 LATIN AMERICA: THAWING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 60 REFRIGERATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 61 NORTH AMERICA: REFRIGERATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 62 EUROPE: REFRIGERATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 63 ASIA PACIFIC: REFRIGERATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 64 LATIN AMERICA: REFRIGERATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 65 ALARM MONITORING SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 66 NORTH AMERICA: ALARM MONITORING SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 EUROPE: ALARM MONITORING SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 68 ASIA PACIFIC: ALARM MONITORING SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 69 LATIN AMERICA: ALARM MONITORING SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 70 INCUBATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 71 NORTH AMERICA: INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 72 EUROPE: INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 73 ASIA PACIFIC: INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 74 LATIN AMERICA: INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 75 CENTRIFUGES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 76 NORTH AMERICA: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 77 EUROPE: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 78 ASIA PACIFIC: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 79 LATIN AMERICA: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 80 OTHER BIOPRESERVATION EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 81 NORTH AMERICA: OTHER BIOPRESERVATION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 82 EUROPE: OTHER BIOPRESERVATION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 83 ASIA PACIFIC: OTHER BIOPRESERVATION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 LATIN AMERICA: OTHER BIOPRESERVATION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 BIOPRESERVATION ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 86 NORTH AMERICA: BIOPRESERVATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 87 EUROPE: BIOPRESERVATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 88 ASIA PACIFIC: BIOPRESERVATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 89 LATIN AMERICA: BIOPRESERVATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 90 BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 91 BIOPRESERVATION MARKET FOR HUMAN TISSUE SAMPLES, BY REGION, 2022–2029 (USD MILLION)
TABLE 92 NORTH AMERICA: BIOPRESERVATION MARKET FOR HUMAN TISSUE SAMPLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 93 EUROPE: BIOPRESERVATION MARKET FOR HUMAN TISSUE SAMPLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 94 ASIA PACIFIC: BIOPRESERVATION MARKET FOR HUMAN TISSUE SAMPLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 LATIN AMERICA: BIOPRESERVATION MARKET FOR HUMAN TISSUE SAMPLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 96 BIOPRESERVATION MARKET FOR ORGANS, BY REGION, 2022–2029 (USD MILLION)
TABLE 97 NORTH AMERICA: BIOPRESERVATION MARKET FOR ORGANS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 98 EUROPE: BIOPRESERVATION MARKET FOR ORGANS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 99 ASIA PACIFIC: BIOPRESERVATION MARKET FOR ORGANS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 100 LATIN AMERICA: BIOPRESERVATION MARKET FOR ORGANS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 101 BIOPRESERVATION MARKET FOR STEM CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 102 NORTH AMERICA: BIOPRESERVATION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 103 EUROPE: BIOPRESERVATION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 104 ASIA PACIFIC: BIOPRESERVATION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 105 LATIN AMERICA: BIOPRESERVATION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 106 BIOPRESERVATION MARKET FOR OTHER BIOSPECIMENS, BY REGION, 2022–2029 (USD MILLION)
TABLE 107 NORTH AMERICA: BIOPRESERVATION MARKET FOR OTHER BIOSPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 108 EUROPE: BIOPRESERVATION MARKET FOR OTHER BIOSPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 109 ASIA PACIFIC: BIOPRESERVATION MARKET FOR OTHER BIOSPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 110 LATIN AMERICA: BIOPRESERVATION MARKET FOR OTHER BIOSPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 111 BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 112 BIOPRESERVATION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 113 NORTH AMERICA: BIOPRESERVATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 114 EUROPE: BIOPRESERVATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 115 ASIA PACIFIC: BIOPRESERVATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 116 LATIN AMERICA: BIOPRESERVATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 117 BIOPRESERVATION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 118 NORTH AMERICA: BIOPRESERVATION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 119 EUROPE: BIOPRESERVATION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 120 ASIA PACIFIC: BIOPRESERVATION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 121 LATIN AMERICA: BIOPRESERVATION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 122 BIOPRESERVATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 123 NORTH AMERICA: BIOPRESERVATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 124 EUROPE: BIOPRESERVATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 125 ASIA PACIFIC: BIOPRESERVATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 126 LATIN AMERICA: BIOPRESERVATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 127 BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 128 BIOPRESERVATION MARKET FOR BIOBANKS, BY REGION, 2022–2029 (USD MILLION)
TABLE 129 NORTH AMERICA: BIOPRESERVATION MARKET FOR BIOBANKS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 130 EUROPE: BIOPRESERVATION MARKET FOR BIOBANKS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 131 ASIA PACIFIC: BIOPRESERVATION MARKET FOR BIOBANKS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 132 LATIN AMERICA: BIOPRESERVATION MARKET FOR BIOBANKS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 133 BIOPRESERVATION MARKET FOR GENE BANKS, BY REGION, 2022–2029 (USD MILLION)
TABLE 134 NORTH AMERICA: BIOPRESERVATION MARKET FOR GENE BANKS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 135 EUROPE: BIOPRESERVATION MARKET FOR GENE BANKS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 136 ASIA PACIFIC: BIOPRESERVATION MARKET FOR GENE BANKS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 137 LATIN AMERICA: BIOPRESERVATION MARKET FOR GENE BANKS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 138 BIOPRESERVATION MARKET FOR HOSPITALS, BY REGION, 2022–2029 (USD MILLION)
TABLE 139 NORTH AMERICA: BIOPRESERVATION MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 140 EUROPE: BIOPRESERVATION MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 141 ASIA PACIFIC: BIOPRESERVATION MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 142 LATIN AMERICA: BIOPRESERVATION MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 143 BIOPRESERVATION MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 144 NORTH AMERICA: BIOPRESERVATION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 145 EUROPE: BIOPRESERVATION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 146 ASIA PACIFIC: BIOPRESERVATION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 147 LATIN AMERICA: BIOPRESERVATION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 148 BIOPRESERVATION MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 149 NORTH AMERICA: BIOPRESERVATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 150 NORTH AMERICA: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 151 NORTH AMERICA: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 152 NORTH AMERICA: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 153 NORTH AMERICA: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 154 NORTH AMERICA: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 155 NORTH AMERICA: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 156 NORTH AMERICA: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 157 US: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 158 US: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 159 US: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 160 US: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 161 US: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 162 US: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 163 US: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 164 US: BIOPRESERVATION MARKET, BY TRANSPLANT TYPE, 2022–2029 (THOUSAND)
TABLE 165 CANADA: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 166 CANADA: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 167 CANADA: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 168 CANADA: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 169 CANADA: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 170 CANADA: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 171 CANADA: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 172 EUROPE: BIOPRESERVATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 173 EUROPE: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 174 EUROPE: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 175 EUROPE: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 176 EUROPE: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 177 EUROPE: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 178 EUROPE: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 179 EUROPE: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 180 GERMANY: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 181 GERMANY: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 182 GERMANY: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 183 GERMANY: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 184 GERMANY: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 185 GERMANY: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 186 GERMANY: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 187 UK: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 188 UK: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 189 UK: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 190 UK: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 191 UK: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 192 UK: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 193 UK: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 194 FRANCE: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 195 FRANCE: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 196 FRANCE: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 197 FRANCE: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 198 FRANCE: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 199 FRANCE: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 200 FRANCE: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 201 ITALY: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 202 ITALY: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 203 ITALY: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 204 ITALY: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 205 ITALY: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 206 ITALY: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 207 ITALY: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 208 SPAIN: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 209 SPAIN: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 210 SPAIN: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 211 SPAIN: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 212 SPAIN: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 213 SPAIN: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 214 SPAIN: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 215 REST OF EUROPE: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 216 REST OF EUROPE: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 217 REST OF EUROPE: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 218 REST OF EUROPE: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 219 REST OF EUROPE: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 220 REST OF EUROPE: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 221 REST OF EUROPE: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 222 ASIA PACIFIC: BIOPRESERVATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 223 ASIA PACIFIC: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 224 ASIA PACIFIC: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 225 ASIA PACIFIC: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 226 ASIA PACIFIC: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 227 ASIA PACIFIC: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 228 ASIA PACIFIC: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 229 ASIA PACIFIC: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 230 CHINA: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 231 CHINA: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 232 CHINA: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 233 CHINA: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 234 CHINA: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 235 CHINA: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 236 CHINA: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 237 JAPAN: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 238 JAPAN: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 239 JAPAN: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 240 JAPAN: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 241 JAPAN: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 242 JAPAN: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 243 JAPAN: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 244 INDIA: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 245 INDIA: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 246 INDIA: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 247 INDIA: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 248 INDIA: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 249 INDIA: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 250 INDIA: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 251 REST OF ASIA PACIFIC: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 252 REST OF ASIA PACIFIC: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 253 REST OF ASIA PACIFIC: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 254 REST OF ASIA PACIFIC: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 255 REST OF ASIA PACIFIC: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 256 REST OF ASIA PACIFIC: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 257 REST OF ASIA PACIFIC: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 258 LATIN AMERICA: BIOPRESERVATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 259 LATIN AMERICA: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 260 LATIN AMERICA: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 261 LATIN AMERICA: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 262 LATIN AMERICA: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 263 LATIN AMERICA: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 264 LATIN AMERICA: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 265 LATIN AMERICA: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 266 BRAZIL: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 267 BRAZIL: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 268 BRAZIL: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 269 BRAZIL: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 270 BRAZIL: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 271 BRAZIL: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 272 BRAZIL: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 273 MEXICO: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 274 MEXICO: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 275 MEXICO: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 276 MEXICO: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 277 MEXICO: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 278 MEXICO: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 279 MEXICO: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 280 REST OF LATIN AMERICA: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 281 REST OF LATIN AMERICA: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 282 REST OF LATIN AMERICA: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 283 REST OF LATIN AMERICA: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 284 REST OF LATIN AMERICA: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 285 REST OF LATIN AMERICA: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 286 REST OF LATIN AMERICA: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 287 MIDDLE EAST & AFRICA: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 288 MIDDLE EAST & AFRICA: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 289 MIDDLE EAST & AFRICA: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 290 MIDDLE EAST & AFRICA: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 291 MIDDLE EAST & AFRICA: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 292 MIDDLE EAST & AFRICA: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 293 MIDDLE EAST & AFRICA: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 294 GCC COUNTRIES: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 295 GCC COUNTRIES: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 296 GCC COUNTRIES: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 297 GCC COUNTRIES: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 298 GCC COUNTRIES: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)
TABLE 299 GCC COUNTRIES: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 300 GCC COUNTRIES: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 301 OVERVIEW OF STRATEGIES ADOPTED BY KEY BIOPRESERVATION COMPANIES
TABLE 302 BIOPRESERVATION MARKET: DEGREE OF COMPETITION
TABLE 303 BIOPRESERVATION MARKET: REGIONAL FOOTPRINT
TABLE 304 BIOPRESERVATION MARKET: PRODUCT FOOTPRINT
TABLE 305 BIOPRESERVATION MARKET: BIOSPECIMEN FOOTPRINT
TABLE 306 BIOPRESERVATION MARKET: APPLICATION FOOTPRINT
TABLE 307 BIOPRESERVATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 308 BIOPRESERVATION MARKET: COMPANY FOOTPRINT (STARTUPS/SMES)
TABLE 309 BIOPRESERVATION MARKET: PRODUCT FOOTPRINT (STARTUPS/SMES)
TABLE 310 BIOPRESERVATION MARKET: REGIONAL FOOTPRINT (STARTUPS/SMES)
TABLE 311 BIOPRESERVATION MARKET: PRODUCT LAUNCHES, JANUARY 2021– APRIL 2024
TABLE 312 BIOPRESERVATION MARKET: DEALS, JANUARY 2021– APRIL 2024
TABLE 313 BIOPRESERVATION MARKET: EXPANSIONS, JANUARY 2021– APRIL 2024
TABLE 314 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
TABLE 315 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 316 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES
TABLE 317 MERCK KGAA: BUSINESS OVERVIEW
TABLE 318 MERCK KGAA: PRODUCTS OFFERED
TABLE 319 MERCK KGAA: EXPANSIONS
TABLE 320 PHC HOLDINGS CORPORATION: BUSINESS OVERVIEW
TABLE 321 EXCHANGE RATES (UTILIZED FOR CONVERSION OF YEN TO USD)
TABLE 322 PHC HOLDINGS CORPORATION: PRODUCTS OFFERED
TABLE 323 PRODUCT LAUNCHES
TABLE 324 AZENTA, INC.: BUSINESS OVERVIEW
TABLE 325 AZENTA, INC.: PRODUCTS OFFERED
TABLE 326 AZENTA, INC.: PRODUCT LAUNCHES
TABLE 327 AZENTA, INC.: DEALS
TABLE 328 AVANTOR, INC.: BUSINESS OVERVIEW
TABLE 329 AVANTOR, INC.: PRODUCTS OFFERED
TABLE 330 AVANTOR, INC.: DEALS
TABLE 331 SARTORIUS AG: BUSINESS OVERVIEW
TABLE 332 EXCHANGE RATES (UTILIZED FOR CONVERSION OF EUR TO USD)
TABLE 333 SARTORIUS AG: PRODUCTS OFFERED
TABLE 334 THERMOGENESIS HOLDINGS, INC.: BUSINESS OVERVIEW
TABLE 335 THERMOGENESIS HOLDINGS, INC.: PRODUCTS OFFERED
TABLE 336 THERMOGENESIS HOLDINGS, INC.: EXPANSIONS
TABLE 337 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW
TABLE 338 BIO-TECHNE CORPORATION: PRODUCTS OFFERED
TABLE 339 BIOLIFE SOLUTIONS, INC.: BUSINESS OVERVIEW
TABLE 340 BIOLIFE SOLUTIONS, INC.: PRODUCTS OFFERED
TABLE 341 BIOLIFE SOLUTIONS, INC.: PRODUCT LAUNCHES
TABLE 342 BIOLIFE SOLUTIONS, INC.: DEALS
TABLE 343 CRYOPORT INC.: BUSINESS OVERVIEW
TABLE 344 CRYOPORT INC.: PRODUCTS OFFERED
TABLE 345 CRYOPORT INC.: DEALS
TABLE 346 SO-LOW ENVIRONMENTAL EQUIPMENT CO.: BUSINESS OVERVIEW
TABLE 347 SO-LOW ENVIRONMENTAL EQUIPMENT CO.: PRODUCTS OFFERED
TABLE 348 SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 349 HELMER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 350 ARCTIKO: COMPANY OVERVIEW
TABLE 351 NIPPON GENETICS EUROPE: COMPANY OVERVIEW
TABLE 352 STEMCELL TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 353 AMSBIO: COMPANY OVERVIEW
TABLE 354 OPS DIAGNOSTICS: COMPANY OVERVIEW
TABLE 355 ASKION GMBH: COMPANY OVERVIEW
TABLE 356 DOHMEYER: COMPANY OVERVIEW
TABLE 357 X-THERMA, INC.: COMPANY OVERVIEW
TABLE 358 IC BIOMEDICAL, LLC: COMPANY OVERVIEW
TABLE 359 TAIYO NIPPON SANSO CORPORATION: COMPANY OVERVIEW
TABLE 360 FROILABO: COMPANY OVERVIEW
TABLE 361 CELLBIOS HEALTHCARE & LIFESCIENCES PVT. LTD.: COMPANY OVERVIEW
 
 
LIST OF FIGURES (53 FIGURES)
 
FIGURE 1 BIOPRESERVATION MARKET: RESEARCH DESIGN METHODOLOGY
FIGURE 2 KEY INDUSTRY INSIGHTS
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION
FIGURE 6 BOTTOM-UP APPROACH: REVENUE-BASED APPROACH
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 8 BIOPRESERVATION MARKET: TOP-DOWN APPROACH
FIGURE 9 DATA TRIANGULATION METHODOLOGY
FIGURE 10 BIOPRESERVATION MARKET, BY PRODUCT, 2024 VS. 2029 (USD BILLION)
FIGURE 11 BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2024 VS. 2029 (USD BILLION)
FIGURE 12 BIOPRESERVATION MARKET, BY APPLICATION, 2024 VS. 2029 (USD BILLION)
FIGURE 13 BIOPRESERVATION MARKET, BY END USER, 2024 VS. 2029 (USD BILLION)
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF BIOPRESERVATION MARKET
FIGURE 15 RISING INVESTMENTS IN REGENERATIVE MEDICINE RESEARCH TO DRIVE MARKET
FIGURE 16 HUMAN TISSUE SAMPLES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC BIOPRESERVATION MARKET IN 2023
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 18 ASIA PACIFIC MARKET TO WITNESS HIGHEST GROWTH FROM 2024 TO 2029
FIGURE 19 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
FIGURE 20 BIOPRESERVATION MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 21 PERCENTAGE OF FDA-APPROVED PERSONALIZED MEDICINES (2015–2022)
FIGURE 22 PATENT ANALYSIS FOR CRYOGENIC STORAGE SYSTEMS (JANUARY 2014–DECEMBER 2023)
FIGURE 23 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING & ASSEMBLY PHASES
FIGURE 24 BIOPRESERVATION MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 25 BIOPRESERVATION MARKET: ECOSYSTEM ANALYSIS
FIGURE 26 KEY PLAYERS IN BIOPRESERVATION MARKET
FIGURE 27 BIOPRESERVATION MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOPRESERVATION PRODUCTS, BY END USER
FIGURE 29 KEY BUYING CRITERIA FOR END USERS
FIGURE 30 BIOPRESERVATION MARKET: INVESTMENT & FUNDING SCENARIO
FIGURE 31 ORGAN TRANSPLANTATION PROCEDURES PERFORMED WORLDWIDE, BY ORGAN TYPE (2024)
FIGURE 32 NORTH AMERICA: BIOPRESERVATION MARKET SNAPSHOT
FIGURE 33 ASIA PACIFIC: BIOPRESERVATION MARKET SNAPSHOT
FIGURE 34 REVENUE ANALYSIS FOR KEY COMPANIES IN BIOPRESERVATION MARKET, 2019–2023 (USD MILLION)
FIGURE 35 BIOPRESERVATION MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
FIGURE 36 BIOPRESERVATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 37 BIOPRESERVATION MARKET: COMPANY FOOTPRINT
FIGURE 38 BIOPRESERVATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 39 EV/EBITDA OF KEY VENDORS
FIGURE 40 EV/REVENUE OF KEY VENDORS
FIGURE 41 BETA (5 YEARS) OF KEY VENDORS
FIGURE 42 1-YEAR PRICE TOTAL RETURN OF KEY VENDORS
FIGURE 43 BIOPRESERVATION MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 44 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
FIGURE 45 MERCK KGAA: COMPANY SNAPSHOT (2023)
FIGURE 46 PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 47 AZENTA, INC.: COMPANY SNAPSHOT (2023)
FIGURE 48 AVANTOR, INC.: COMPANY SNAPSHOT (2023)
FIGURE 49 SARTORIUS AG: COMPANY SNAPSHOT (2023)
FIGURE 50 THERMOGENESIS HOLDINGS, INC.: COMPANY SNAPSHOT (2023)
FIGURE 51 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 52 BIOLIFE SOLUTIONS, INC.: COMPANY SNAPSHOT (2023)
FIGURE 53 CRYOPORT INC.: COMPANY SNAPSHOT (2023)

The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Biopreservation market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are:

Collecting Secondary Data

The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Biopreservation market. A database of the key industry leaders was also prepared using secondary research.

Collecting Primary Data

The primary research data was conducted after acquiring knowledge about the Biopreservation market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as biobanks, gene banks, hospitals, and academic research institute) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and GCC. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Breakdown of Primary Participants:

Biopreservation Market Size, and Share

Note 1: *Others include sales managers, marketing managers, and product managers.

Note 2: Tiers are defined based on a company’s total revenue as of 2023: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

All major product manufacturers offering various Biopreservation were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value Biopreservation market was also split into various segments and subsegments at the region and country level based on:

  • Product mapping of various manufacturers for each type of Biopreservation market at the regional and country-level 
  • Relative adoption pattern of each Biopreservation market among key application segments at the regional and/or country-level 
  • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
  • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

Global Biopreservation Market Size: Top Down Approach

Biopreservation Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Biopreservation Market Size: Bottom-Up Approach

Biopreservation Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Biopreservation industry.

Market Definition

Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. The different types of biospecimen stored include human tissue samples, stem cells, and organs, which are majorly used in therapeutic and research applications. These high-yielding cell lines need to be preserved in order to provide optimum yield, viability, and productivity, which can be achieved by cryopreservation and vitrification in a hypothermic storage environment. Biopreservation is a rapidly emerging field of specimen procurement, processing, preservation and banking which requires a close collaboration between clinicians, engineers and scientists coming from academia, small private enterprises or huge industrial companies.

Key Stakeholders

  • Senior Management
  • Finance/Procurement Department
  • Doctors/HCPs
  • Researchers
  • Lab Managers/Technicians
  • End Users/Operators

Report Objectives

  • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To define, describe, segment, and forecast the Biopreservation market by product, biospecimen, application, end user, and region.
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall Biopreservation market
  • To forecast the size of the Biopreservation market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC.
  • To profile key players in the Biopreservation market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the Biopreservation market.
  • To benchmark players within the Biopreservation market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

MarketsandMarkets offers the following customizations for this market report:

  • Additional country-level analysis of the Biopreservation market
  • Profiling of additional market players (up to 5)

Product Analysis

  • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Biopreservation Market
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 1305
Published ON
May, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Biopreservation Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
Website Feedback